Your browser doesn't support javascript.
loading
Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trial.
Estephan, Lila; Lin, Ying-Chin; Lin, Yi-Tsung; Chen, Yen-Hsu; Pan, Sung-Ching; Hsieh, Szu-Min; Torkehagen, Paal Fure; Weng, Yi-Jen; Cheng, Hao-Yuan; Estrada, Josue Antonio; Waits, Alexander; Chen, Charles; Lien, Chia En.
Affiliation
  • Estephan L; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Lin YC; Department of Family Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Lin YT; Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Chen YH; Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan.
  • Pan SC; Department of Internal Medicine, Division of Infectious Diseases, National Taiwan University Hospital, Taipei City, Taiwan; College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Hsieh SM; Department of Internal Medicine, Division of Infectious Diseases, National Taiwan University Hospital, Taipei City, Taiwan; College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Torkehagen PF; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Weng YJ; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Cheng HY; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Estrada JA; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Waits A; Medigen Vaccine Biologics Corporation, Taipei, Taiwan; Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Chen C; Medigen Vaccine Biologics Corporation, Taipei, Taiwan; Temple University, Philadelphia, PA 19122, USA.
  • Lien CE; Medigen Vaccine Biologics Corporation, Taipei, Taiwan; Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan. Electronic address: allenlien@medigenvac.com.
Vaccine ; 41(23): 3497-3505, 2023 05 26.
Article in En | MEDLINE | ID: mdl-37080829
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Clinical_trials Limits: Adult / Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Clinical_trials Limits: Adult / Humans Language: En Year: 2023 Type: Article